Dr Cecilia Oliveri is a highly accomplished and respected physician double boarded in Anatomic and Clinical
Pathology, Cytopathology, Oncologic Surgical Pathology and Gastrointestinal Pathology.

She earned her Doctor of Medicine degree from Universidad Central de Venezuela, Caracas, Venezuela. Dr
Cecilia Oliveri completed a prestigious fellowship in Oncologic Surgical Pathology and Cytopathology at the
renowned H Lee Moffitt Cancer Center and Research Institute, University of South Florida and Anatomic and
Clinical Pathology at the University of South Alabama College of Medicine Mobile, Alabama.

As a double board-certified physician in Anatomic and Clinical Pathologist and Cytopathologist and Oncologic
Surgical Pathology, Dr. Oliveri has authored numerous peer- reviewed publications and brings a wealth of
clinical knowledge and expertise to her capacity as Clinical Laboratory Director.

Dr. Cecilia Oliveri will exercise overarching leadership of the laboratory’s clinical operations and ensure
rigorous adherence to CLIA and all pertinent federal, state and accrediting‑body standards are upheld to the
highest levels of diagnostic accuracy and quality control. In this capacity, she will direct and supervise
laboratory personnel, lead the development of advanced testing methodologies and implement a
comprehensive quality‑management framework to govern test validation, monitoring accuracy and
performance metrics, to ensure the delivery of reliable and clinically actionable patient results.

As Clinical Laboratory Director, Dr. Cecilia Oliveri will also conduct formal competency assessments to
optimize professional development, workforce performance and operational efficiency. Additionally, she will
offer expert consultation and support to our healthcare community, contributing to high‑quality patient care
and informed clinical decision‑making.

Stephanie Altidort is a laboratory professional with a strong academic foundation and technical expertise in molecular diagnostics and genomic science. She earned her Bachelor of Science in Neuroscience from Florida Atlantic University, where she developed a foundational understanding of neurobiological processes and cellular mechanisms relevant to molecular medicine. She holds certification as a Molecular Diagnostics Technologist through the American Medical Technologists and is currently pursuing board certification in Cytogenetics through the American Society for Clinical Pathology. Ms. Altidort is licensed as a Florida Supervisor in Molecular Pathology by the Florida Department of Health and maintains certification in Basic Life Support through the National CPR Foundation.

In her role as General Supervisor, Ms. Altidort is entrusted with critical responsibilities aligned with Clinical Laboratory Improvement Amendments (CLIA) regulatory standards. She provides direct supervision of high-complexity molecular testing procedures, ensuring the integrity and validity of all phases of laboratory operations. Her responsibilities include reviewing and authorizing test procedures, monitoring quality assurance and quality control systems, and validating instrument performance to uphold analytical accuracy and reproducibility.

Ms. Altidort plays an integral role in personnel management, including the evaluation of staff competency, coordination of continuing education, and oversight of protocol adherence. She collaborates with the laboratory director and technical leadership in the implementation of new assays, assessment of workflow efficiency, and maintenance of documentation required for regulatory compliance and laboratory accreditation.

With a commitment to scientific rigor and operational excellence, Ms. Altidort advances the quality of diagnostic services through precise supervision, regulatory expertise, and a focus on clinical impact. Her contributions are essential to maintaining the laboratory’s adherence to best practices and its mission of delivering accurate, timely, and clinically actionable results.

Alyssa Craig serves as the Genetics Supervisor and Data Specialist at Oncosure Testing, where she leads laboratory operations supporting advanced genetic and oncology testing. She oversees the full testing lifecycle, including sample processing, assay execution, quality control, and bioinformatics workflows, ensuring accuracy, efficiency, and the highest standards of data integrity.

In her role, Alyssa drives assay development and validation initiatives, maintains robust quality systems, and ensures compliance with CLIA, HIPAA, OSHA, and applicable state regulations. She is instrumental in maintaining inspection readiness, implementing continuous process improvements, and supporting scalable laboratory growth.

With a strong background in molecular diagnostics, Alyssa brings extensive experience across next-generation sequencing (NGS), pharmacogenomics, qRT-PCR, and clinical chemistry. She has successfully led high-complexity laboratory teams, implemented new testing platforms, and supported laboratories through validation and regulatory consulting.

Alyssa is triple board certified through the American Association of Bioanalysts (AAB), American Society for Clinical Pathology (ASCP), and American Medical Technologists (AMT), and holds a Clinical Laboratory Supervisor license in Molecular Pathology. She earned her Bachelor of Science in Forensic Chemistry and is currently pursuing her PhD in Biochemistry and Molecular Biology at the University of Miami. Alyssa is dedicated to advancing precision medicine through high-quality genetic testing and innovative laboratory practices.

William Wysock is a seasoned molecular scientist with over two decades of experience in clinical and translational research, specializing in molecular diagnostics and infectious disease biology. He holds a Bachelor of Arts in Writing from Loyola University of Maryland and a Master of Science in Biology from the Catholic University of America. His unique interdisciplinary background combines scientific rigor with clear, analytical communication, a valuable asset in both research and laboratory operations.

Mr. Wysock is certified in Molecular Biology by the American Society for Clinical Pathology and has extensive expertise in advanced molecular methodologies, including polymerase chain reaction (PCR) techniques, next-generation sequencing (NGS), and the implementation of laboratory quality systems. He is also trained in Six Sigma methodologies and holds a Green Belt certification, underscoring his commitment to operational efficiency and process improvement.

In his role as Molecular Scientist, Mr. Wysock is principally responsible for overseeing the laboratory's validation processes. This includes designing and executing method verification studies, analyzing performance metrics, and ensuring all assays meet stringent analytical and clinical standards prior to implementation. His in-depth knowledge of assay development and regulatory requirements plays a critical role in maintaining the scientific credibility and compliance integrity of the laboratory.

Mr. Wysock also serves as the laboratory’s primary resource for complex technical inquiries. He provides expert guidance on molecular workflows, troubleshooting protocols, and optimizing assay performance, thereby supporting both day-to-day operations and long-term innovation. His leadership in this capacity ensures that laboratory personnel are equipped with the technical insights necessary for high-complexity testing.

A prolific contributor to the scientific literature, Mr. Wysock has authored numerous peer-reviewed publications in the fields of molecular diagnostics and infectious disease research. His scholarly work reflects a sustained commitment to advancing laboratory science and integrating evidence-based practices into clinical diagnostics. Through his analytical acumen, mentorship, and research-driven approach, William Wysock significantly enhances the laboratory's capacity for precision medicine and scientific advancement.